Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

The UK’s biggest Afrobeats songs of the week based on sales and streams across a seven day period, compiled by the Official Charts Company.

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

Hope helped me navigate my testicular cancer diagnosis at 20, shaping my resilience and guiding my journey as a survivor.

Corvus is currently enrolling patients in a registrational Phase 3 clinical trial of soquelitinib for relapsed Peripheral T cell lymphoma (PTCL) across multiple sites in the U.S., Canada ...

The data displayed for this chart goes back to 1994, however we hope to be able to offer deeper historic information at a future point ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

HONG KONG - HUTCHMED (China) Limited (Nasdaq/AIM:HCM; HKEX:13) has received conditional approval from China’s National Medical (TASE:BLWV) Products Administration (NMPA) for TAZVERIK® (tazemetostat) ...

Follicular lymphoma is the second most common subtype of non-Hodgkin’s lymphoma, accounting for 20-30% of all cases. In 2022, there were approximately 81,000 new cases in China and 78,000 in the ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Expansion cohorts include ovarian cancer, all tumor types and T-cell lymphoma (including CTCL). The dose escalation in Phase 1 part B has been completed and the Phase 2a dose expansion study for ...